Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title
PA-19-126 Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K01 Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
PA-19-119 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K23 Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
PA-19-127 Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K01 Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
PA-19-116 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K08 Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
PA-19-124 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K25 Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)
PA-19-129 Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K99/R00 NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)
PA-19-117 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K08 Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
PA-19-125 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2022 K25 Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required)
RFA-EB-18-004 February 22, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
February 23, 2019 R24 Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
RFA-OD-19-014 March 19, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
March 20, 2019 U01 NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)
RFA-NS-19-018 January 9, 2019, March 22, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, February 21, 2021, by 5:00 PM local time of applicant organization. February 23, 2021 UH3 HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
RFA-EB-18-003 March 22, 2019, June 20, 2019, October 22, 2019, February 21, 2020, June 22, 2020, October 21, 2020, February 22, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
February 23, 2021 U18 HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
RFA-NS-19-016 January 9, 2019, March 22, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, February 21, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. February 23, 2021 UG3/UH3 HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
RFA-NS-19-017 January 9, 2019; March 22, 2019; June 21, 2019; October 21, 2019; February 21, 2020; June 22, 2020; October 21, 2020; February 21, 2021, by 5:00 PM local time of applicant organization. February 23, 2021 U44 HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
RFA-HD-19-025 March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
March 30, 2019 PL1 HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed)
RFA-AR-19-028 March 20, 2019, by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement.
March 21, 2019 UH2/UH3 HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional)
RFA-AR-19-026 March 20, 2019, by 5:00 PM local time of applicant organization.

No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
March 21, 2019 U19 HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19 Clinical Trial Optional)
RFA-AR-19-027 March 20, 2019, by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement
March 21, 2019 U24 HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24 Clinical Trial Not Allowed)
RFA-DA-19-034 March 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
March 14, 2019 U24 HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed)
RFA-DA-19-035 March 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
March 14, 2019 UG3/UH3 HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)
top of pageBACK TO TOP